U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

SARGASSUM MUTICUM

MORE DETAILS

98G0172R0Y

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Salicylic Acid by Bejing Rimeng Biological Technology Co Ltd
(2009)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23c8b614-173c-4e4a-88ce-0ea808638c16
First approved in 2009
Source:
Salicylic Acid by Bejing Rimeng Biological Technology Co Ltd
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=23c8b614-173c-4e4a-88ce-0ea808638c16
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966